Hematology/Oncology

146 - A novel microfluidic leukapheresis device continuously and selectively removes leukocytes from circulation in rats

147 - Assessing Psychosocial Risk Factors in Children with Sickle Cell Disease

148 - Bile Acid Metabolism: a potential indicator for red blood cell transfusion in preterm infants

149 - Emergency Steroid Treatment of Superior Vena Cava Syndrome Secondary to Malignant Mediastinal Mass Resulting In Diagnostic Uncertainty Due to Pre-Biopsy Administration

150 - Epidemiology, Trends, and Healthcare Burden of Post-Transplant Lymphoproliferative Disorder among Pediatric Recipients of Solid Organ or Hematopoietic Stem Cell Transplant

151 - Intravenous iron infusions in pediatric patients: a single institution retrospective review of efficacy and safety of IV iron infusions

152 - Real-World Demographics, Clinical Characteristics, and Treatment Patterns of Patients Treated With Emapalumab for Hemophagocytic Lymphohistiocytosis (HLH) and Non-HLH Conditions in the US (REAL-HLH

155 - Examining variability in clinical measurements of height and weight data within the first year of pediatric cancer treatment

156 - First Report of Tumor-Informed Circulating Tumor DNA in Fibrolamellar Carcinoma in Adolescents and Young Adults: 51 patients.

157 - Incidence of Horner’s Syndrome in Pediatric Neuroblastoma

158 - Pediatric oncology multidisciplinary provider perspectives on chemotherapy-induced nausea and vomiting (CINV) management and preferred improvement approaches

159 - Perception of Chemotherapy-Induced Nausea and Vomiting Control in Pediatric Patients

160 - Severe Hemolytic Anemia and Aplastic Crisis with Active COVID Infection in the setting of undiagnosed Hereditary Stomatocytosis

161 - Targeting Treatment-resistant Medulloblastoma

162 - Distress in Caregivers of Children Referred to a Cancer Predisposition Syndromes Clinic